BCB Medical has been at the forefront of medical technology innovation since 2003.
Over 100 centres
across the UK and Nordics
trust HepCARE to help them manage challenging
patient cohorts.
Customers & Partners
What Sets Us Apart
HepCARE is actively used by approximately 30 hospitals in the UK. We work closely with the end users and the features and the content of the HepCARE system is developed based on users’ need. The collaboration is led by the joint steering committee with clinicians and end users from leading centres including King’s College Hospital, St. George’s University Hospitals and Manchester University NHS Foundation Trust (MFT).
We have strong collaboration with different shareholders and our partner network is constantly expanding. We have partnerships with UK HSA (UK Health Security Agency) and HCV Elimination Programme in the UK and our global partners give strong background to develop new, innovative and cost-effective solutions to support the treatment of hepatitis and Hepatology.
_edited_edited.png)
_edited.png)
“Best tool in clinic use since the iPhone and has significantly helped me in every day practice”
– Clinician
“The Health Solutions team have been very supportive with regard to adapting HepCARE for research projects. We are due to launch HepCARE for us in clinical practice in the upcoming weeks in order to better manage our chronic hepatitis B caseload. We anticipate this will help with identifying the lost to follow-up cohort ”
– ODN Manager
“I have been using HepCARE for a few years and find it a very useful system. As HepCARE interfaces with Pathology, it saves me a lot of time having to search for SVR 12 and other bloods required for NHSE. MDT forms are clear and readable and hold a lot of information that is required for NHSE. Each individual patient has their own check list to ensure when submitting patients to ARDEN/Gem, all details are present. Help is at hand for is I have a query or something rectifying”
– ODN Manager
